ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,370.33
-0.55%
Dow Jones
39,671.04
-0.51%
Gold vs US Dollar
2,372.19
-0.41%
Brent Oil
81.245
-0.35%
Bitcoin
69,400.88
0.43%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Eiger Biopharmaceuticals Com (CLDN)

  7. Eiger Biopharmaceuticals Com (CLDN) News

CELLADON CORP (CLDN)

Eiger Biopharmaceuticals Com
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:CLDN
DateTimeSourceHeadlineSymbolCompany
25/03/201623:21Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:CLDNEiger Biopharmaceuticals Com
25/03/201623:19Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:CLDNEiger Biopharmaceuticals Com
25/03/201623:17Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:CLDNEiger Biopharmaceuticals Com
25/03/201623:15Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:CLDNEiger Biopharmaceuticals Com
25/03/201623:11Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:CLDNEiger Biopharmaceuticals Com
25/03/201623:08Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:CLDNEiger Biopharmaceuticals Com
25/03/201623:06Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:CLDNEiger Biopharmaceuticals Com
23/03/201610:12Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CLDNEiger Biopharmaceuticals Com
21/03/201620:19Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CLDNEiger Biopharmaceuticals Com
21/03/201620:05GlobeNewswire Inc.Celladon Announces Results of Special MeetingNASDAQ:CLDNEiger Biopharmaceuticals Com
14/03/201620:12Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:CLDNEiger Biopharmaceuticals Com
09/03/201621:39Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CLDNEiger Biopharmaceuticals Com
09/03/201621:37Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:CLDNEiger Biopharmaceuticals Com
29/02/201622:27Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CLDNEiger Biopharmaceuticals Com
29/02/201613:00PR Newswire (US)Eiger to Participate in Cowen & Company 2016 Health Care ConferenceNASDAQ:CLDNEiger Biopharmaceuticals Com
16/02/201619:44Edgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:CLDNEiger Biopharmaceuticals Com
16/02/201619:44Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CLDNEiger Biopharmaceuticals Com
16/02/201616:29Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:CLDNEiger Biopharmaceuticals Com
16/02/201611:20Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CLDNEiger Biopharmaceuticals Com
16/02/201611:19Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:CLDNEiger Biopharmaceuticals Com
16/02/201611:01Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:CLDNEiger Biopharmaceuticals Com
11/02/201622:31Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CLDNEiger Biopharmaceuticals Com
11/02/201622:18Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CLDNEiger Biopharmaceuticals Com
10/02/201622:16Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CLDNEiger Biopharmaceuticals Com
10/02/201622:15Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:CLDNEiger Biopharmaceuticals Com
10/02/201621:58GlobeNewswire Inc.Celladon Sets Date for Special Meeting of StockholdersNASDAQ:CLDNEiger Biopharmaceuticals Com
08/02/201622:25Edgar (US Regulatory)Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a)NASDAQ:CLDNEiger Biopharmaceuticals Com
29/01/201612:28Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:CLDNEiger Biopharmaceuticals Com
22/01/201611:12Edgar (US Regulatory)Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a)NASDAQ:CLDNEiger Biopharmaceuticals Com
19/01/201621:08Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CLDNEiger Biopharmaceuticals Com
 Showing the most relevant articles for your search:NASDAQ:CLDN

Your Recent History

LSE
ITM
Itm Power
LSE
AMRQ
Amaroq Minerals
LSE
MNL
Manchester & London Inve...
LSE
W7L
Warpaint London
LSE
KIE
Kier
LSE
VLG
Venture Life
LSE
VAL
Valirx
LSE
BP.
Bp
LSE
GKP
Gulf Keystone Petroleum
LSE
IMB
Imperial Brands
LSE
EMG
Man
LSE
GPM
Golden Prospect Precious...
LSE
EME
Empyrean Energy
LSE
HL.
Hargreaves Lansdown
LSE
STX
Shield Therapeutics
LSE
ITV
Itv
Delayed Upgrade Clock
    ADVFN Logo

    United Kingdom
    Company
    Business
    Popular
    Get The App

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved